Utidelone monotherapy suggesting clinical efficacy in heavily pretreated platinum-resistant high-grade serous ovarian cancer: a case report

Abstract Background Platinum-resistant ovarian cancer (OC) presents a significant therapeutic challenge with limited effective salvage options and dismal survival outcomes. Utidelone (UTD1), a novel synthetic epothilone B analogue that circumvents P-glycoprotein-mediated drug efflux, demonstrates pr...

Description complète

Détails bibliographiques

Auteurs principaux:	Feifei Kong, Ying Gao, Lianzi Wei, Meng Yang, Haixia Shan
Format:	Artigo
Langue:	Inglês
Publié:	SpringerOpen 2026-04-01
Collection:	Bulletin of the National Research Centre
Sujets:	Ovarian cancer Utidelone Epothilone Platinum resistance Progression-free survival
Accès en ligne:	https://doi.org/10.1186/s42269-026-01433-8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!